Sleep, once the most private of physiologic acts, is being reverse‑engineered in public and sold back to consumers as a...
Read moreThe exam room has acquired a silent participant — the algorithm — and pediatric health is increasingly negotiated in its...
Read moreThe intestine has been promoted from an organ system to an explanatory universe. Search and social discourse over the past...
Read moreInfection risk has returned to everyday consciousness, not as a pandemic emergency but as a background condition of modern life....
Read moreHealth misinformation and disinformation across TikTok, Instagram, YouTube Shorts, and algorithm-driven search feeds have become one of the most actively...
Read moreThe system is not tired — it is overheating, and clinicians are simply where the warning lights happen to be...
Read moreThe center of gravity in behavioral health has shifted quietly but decisively — away from institutions and into networks. Search...
Read morePeer‑reviewed evidence still matters, but it does not close deals Clinical publications continue to anchor credibility, particularly for tools that...
Read moreThe electronic health record did not break medicine’s intellect. It broke its time. Documentation expanded, inboxes multiplied, and clinicians began...
Read moreHealthcare consumerism introduces a set of unresolved tensions that resist simple resolution. Efficiency and equity, often presented as complementary goals,...
Read morePublic health guidance has long presumed a degree of agency that many Americans do not fully possess. Recommendations are issued...
Read moreA single stillbirth can unmask the fissures in our healthcare system. Midyear data from the Centers for Disease Control and...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy